Results 111 to 120 of about 7,788 (207)

Brief Report: Real-World Uptake and Clinical Outcomes of Long-Acting Injectable Cabotegravir/Rilpivirine in the United States, 2021-2023. [PDF]

J Acquir Immune Defic Syndr
O'Shea J, Derton A, Henson J, Iqbal K, Briggs-Hagen M, Kourtis AP, Buchacz K.   +6 more
europepmc   +1 more source

Red cell exchange removes apixaban in patients with sickle cell disease. [PDF]

Transfusion
Boyle K, Evans M, Mansfield C, Notini M, Garrett ME, Arepally GM, Lee GM.   +6 more
europepmc   +1 more source

KRAS Footprints in the Skin: Leveraging Targeted Therapy for Unresectable Intra-Cerebral AVM. [PDF]

Pediatr Dermatol
Zhang D, Kwon JM, Aagaard-Kienitz B, Rebsamen SL, Mc Dermott SE, Arkin LM.   +5 more
europepmc   +1 more source

Novel bioactive compounds from marine-derived endosymbiotic Penicillium fungi reported during 2020-2025. [PDF]

Nat Prod Bioprospect
Omran SA, Elnaggar MS, Youssef FS, El-Moghazy SA.   +3 more
europepmc   +1 more source

Synthesis and reactivity of nitrogen-containing strained cyclic 1,2,3-trienes. [PDF]

Nat Synth
Witkowski DC, Turner DW, Bulger AS, Houk KN, Garg NK.   +4 more
europepmc   +1 more source

Use of Apixaban for Venous Thromboembolism Prophylaxis in an Older Hemodialysis Patient After Total Knee Replacement: A Case Report. [PDF]

Am J Case Rep
Alanizi AH, Alanazi NH, Bin Makhash AS, Alotibi RH, Qubaiban RM, Badawoud AM, AlSaati MF.   +6 more
europepmc   +1 more source

Switching to doravirine-based antiretroviral therapy without genotypic resistance tests in virologically suppressed people with HIV. [PDF]

AIDS
Mason J, Kohli M, Taiwo E, Maan I, Gharib Y, Suonpera E, Barlow M, Olcott F, Waters L, Arenas-Pinto A, Gilson R, Pett S.   +11 more
europepmc   +1 more source

Brief Report: Dolutegravir-Based Therapy, Diet, Physical Activity, and Weight Gain: A 48-week Prospective Cohort in South Africa. [PDF]

J Acquir Immune Defic Syndr
Tien D, Chandiwana N, Shazi G, Chen G, Mabweazara S, Moosa MS, Gupta RK, Pillay D, Marconi VC, Hedt-Gauthier B, Venter WDF, Siedner MJ, McCluskey SM, Manne-Goehler J.   +13 more
europepmc   +1 more source

<i>In vitro</i> comparison of the effects of abelacimab, dalteparin, and apixaban on catheter-induced clotting and thrombin generation. [PDF]

Res Pract Thromb Haemost
Yin R, Guo X, Fredenburgh JC, Weitz JI.
europepmc   +1 more source

A randomised, open-label clinical study on the efficacy of baloxavir marboxil and oseltamivir for post-exposure prevention of influenza in a hospital setting: a study protocol. [PDF]

BMJ Open
Li X, Chu Z, Peng M, Yan K, Guan Y, Yang C, Xu J, Qiu L, Liu T.   +8 more
europepmc   +1 more source